|
male meiosis
|
GO:0007140 |
37 |
0.256
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.227
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.155
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.145
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.135
|
|
|
response to cell cycle checkpoint signaling
|
GO:0072396 |
1 |
0.131
|
|
|
dna repair
|
GO:0006281 |
107 |
0.115
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.108
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.102
|
|
|
microtubule nucleation
|
GO:0007020 |
2 |
0.091
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.071
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.064
|
|
|
microtubule polymerization or depolymerization
|
GO:0031109 |
26 |
0.060
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.059
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.056
|
|
|
microtubule cytoskeleton organization involved in mitosis
|
GO:1902850 |
4 |
0.050
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.049
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.049
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.045
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.039
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.037
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.036
|
|
|
metaphase plate congression
|
GO:0051310 |
2 |
0.036
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.036
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.036
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.036
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.035
|
|
|
establishment of meiotic spindle orientation
|
GO:0051296 |
1 |
0.034
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.034
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.033
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.032
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.030
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.028
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.028
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.028
|
|
|
cleavage furrow formation
|
GO:0036089 |
2 |
0.027
|
|
|
dna packaging
|
GO:0006323 |
30 |
0.026
|
|
|
mitotic sister chromatid cohesion
|
GO:0007064 |
1 |
0.026
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.026
|
|
|
mitotic chromosome condensation
|
GO:0007076 |
1 |
0.026
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.025
|
|
|
microtubule polymerization
|
GO:0046785 |
12 |
0.025
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.025
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.025
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.025
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.024
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.024
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.024
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.024
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.023
|
|
|
gland development
|
GO:0048732 |
330 |
0.023
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.022
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.022
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.022
|
|
|
dna dependent dna replication maintenance of fidelity
|
GO:0045005 |
3 |
0.022
|
|
|
positive regulation of mitotic metaphase anaphase transition
|
GO:0045842 |
2 |
0.022
|
|
|
spindle assembly involved in female meiosis
|
GO:0007056 |
3 |
0.022
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.021
|
|
|
meiotic spindle organization
|
GO:0000212 |
9 |
0.021
|
|
|
spindle assembly involved in meiosis
|
GO:0090306 |
4 |
0.021
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.021
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.021
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.021
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.021
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.020
|
|
|
cell division
|
GO:0051301 |
120 |
0.020
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.020
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.020
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.020
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.020
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.020
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.020
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.019
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.019
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.019
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.019
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.019
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.018
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.018
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.018
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.018
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.018
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.018
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.018
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.018
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.018
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.017
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.017
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.017
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.017
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.017
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.017
|
|
|
cation transport
|
GO:0006812 |
399 |
0.017
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.017
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.017
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.016
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.016
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.016
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.016
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.016
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.016
|
|
|
meiotic dna repair synthesis
|
GO:0000711 |
4 |
0.016
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.016
|
|
|
reciprocal meiotic recombination
|
GO:0007131 |
16 |
0.016
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.016
|
|
|
regulation of mitotic spindle organization
|
GO:0060236 |
2 |
0.016
|
|
|
cellularization
|
GO:0007349 |
1 |
0.016
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.016
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.016
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.016
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.016
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.016
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.016
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.016
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.015
|
|
|
spindle assembly involved in mitosis
|
GO:0090307 |
4 |
0.015
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.015
|
|
|
protein complex disassembly
|
GO:0043241 |
40 |
0.015
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.015
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.015
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.015
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
49 |
0.015
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.015
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.015
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.015
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.015
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.015
|
|
|
gonad development
|
GO:0008406 |
141 |
0.014
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.014
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.014
|
|
|
spindle assembly
|
GO:0051225 |
13 |
0.014
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.014
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.014
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.014
|
|
|
negative regulation of microtubule polymerization or depolymerization
|
GO:0031111 |
15 |
0.014
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.014
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.014
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.014
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.014
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.014
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.013
|
|
|
double strand break repair
|
GO:0006302 |
48 |
0.013
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.013
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.013
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.013
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.013
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.013
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.013
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.013
|
|
|
dna biosynthetic process
|
GO:0071897 |
22 |
0.013
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.013
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.013
|
|
|
regulation of transcription involved in g1 s transition of mitotic cell cycle
|
GO:0000083 |
3 |
0.013
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.013
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.013
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.013
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.013
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.012
|
|
|
ossification
|
GO:0001503 |
216 |
0.012
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.012
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.012
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.012
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.012
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.012
|
|
|
rna processing
|
GO:0006396 |
105 |
0.012
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.012
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.012
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.012
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.012
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.012
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.012
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.012
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.012
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.012
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.012
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.012
|
|
|
signal transduction involved in cell cycle checkpoint
|
GO:0072395 |
3 |
0.012
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.012
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.012
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.012
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.012
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.012
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.012
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.011
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.011
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.011
|
|
|
response to corticosterone
|
GO:0051412 |
1 |
0.011
|
|
|
astral microtubule organization
|
GO:0030953 |
3 |
0.011
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.011
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.011
|
|
|
microtubule depolymerization
|
GO:0007019 |
15 |
0.011
|
|
|
protein processing
|
GO:0016485 |
163 |
0.011
|
|
|
regulation of spindle organization
|
GO:0090224 |
2 |
0.011
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.011
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.011
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.011
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.011
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
43 |
0.011
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.011
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.011
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.011
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.011
|
|
|
dna endoreduplication
|
GO:0042023 |
4 |
0.011
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.011
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.011
|
|
|
regulation of microtubule cytoskeleton organization
|
GO:0070507 |
37 |
0.011
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.011
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.011
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.011
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.011
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.011
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.011
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.010
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.010
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.010
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.010
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.010
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.010
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.010
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.010
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.010
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.010
|
|
|
cellular protein complex disassembly
|
GO:0043624 |
36 |
0.010
|
|
|
protein depolymerization
|
GO:0051261 |
34 |
0.010
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.010
|
|
|
pallium development
|
GO:0021543 |
120 |
0.010
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.010
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.010
|
|